Lisa Anson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lisa Anson
Lisa Anson is recorded as CEO at Skye Bioscience, Inc. (SKYE). Skye Bioscience, Inc. reported in an 8-K filed August 14, 2026 that Lisa Anson was appointed Chief Executive Officer.
“Upon completion of the Transaction, the current Redx management team will transition to lead the combined company, Fibrx, with Lisa Anson as Chief Executive Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-08-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Skye Bioscience, Inc.
Other people whose current roles at this company are on record from its filings.
- Punit Dhillon CEO, Chief Accounting Officer, Board Member
- Paul Grayson Chairman, Board Member
- Elena Traistaru CFO
- Kaitlyn Arsenault CFO
- Peter Collum CFO
- Tu Diep COO
- Dr. Cliff Jones CTO
- Richard Janney Chief Accounting Officer
- Andrew J. Schwab Board Member
- Andrew Schwab Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.